Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

Christoph Licht, Larry A. Greenbaum, Petra Muus, Sunil Babu, Camille L. Bedrosian, David J. Cohen, Yahsou Delmas, Kenneth Douglas, Richard R. Furman, Osama A. Gaber, Timothy Goodship, Maria Herthelius, Maryvonne Hourmant, Christophe M. Legendre, Giuseppe Remuzzi, Neil Sheerin, Antonella Trivelli, Chantal Loirat

Research output: Contribution to journalArticlepeer-review

256 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies'. Together they form a unique fingerprint.

Medicine & Life Sciences